377 related articles for article (PubMed ID: 16387578)
1. Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation.
Johnson M
J Allergy Clin Immunol; 2006 Jan; 117(1):18-24; quiz 25. PubMed ID: 16387578
[TBL] [Abstract][Full Text] [Related]
2. Beta2-adrenoceptors: mechanisms of action of beta2-agonists.
Johnson M
Paediatr Respir Rev; 2001 Mar; 2(1):57-62. PubMed ID: 16263481
[TBL] [Abstract][Full Text] [Related]
3. The beta-adrenoceptor.
Johnson M
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 3):S146-53. PubMed ID: 9817738
[TBL] [Abstract][Full Text] [Related]
4. [Polymorphism of beta 2-adrenergic receptors].
Weglarz L; Grzanka A; Kierot J; Wilczok T
Wiad Lek; 2003; 56(5-6):283-8. PubMed ID: 14526489
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional response to persistent beta2-adrenergic receptor signaling reveals regulation of phospholamban, which alters airway contractility.
McGraw DW; Fogel KM; Kong S; Litonjua AA; Kranias EG; Aronow BJ; Liggett SB
Physiol Genomics; 2006 Oct; 27(2):171-7. PubMed ID: 16849635
[TBL] [Abstract][Full Text] [Related]
6. Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells.
Kaur M; Chivers JE; Giembycz MA; Newton R
Mol Pharmacol; 2008 Jan; 73(1):203-14. PubMed ID: 17901197
[TBL] [Abstract][Full Text] [Related]
7. Long-acting beta2-adrenoceptor agonists: a smart choice for asthma?
Lipworth BJ
Trends Pharmacol Sci; 2007 Jun; 28(6):257-62. PubMed ID: 17466387
[TBL] [Abstract][Full Text] [Related]
8. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
9. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
[TBL] [Abstract][Full Text] [Related]
10. Beta2-adrenoceptor polymorphisms and obstructive airway diseases: important issues of study design.
Yang IA; Ng T; Molenaar P; Fong KM
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1029-36. PubMed ID: 17714090
[TBL] [Abstract][Full Text] [Related]
11. Limited beta2-adrenoceptor haplotypes display different agonist mediated airway responses in asthmatics.
van Veen A; Wierenga EA; Westland R; Weller FR; Hart GA; Jansen HM; Jonkers RE
Respir Res; 2006 Jan; 7(1):19. PubMed ID: 16448568
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenoceptor responses of the airways: for better or worse?
Broadley KJ
Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase 4 and tolerance to beta 2-adrenoceptor agonists in asthma.
Giembycz MA
Trends Pharmacol Sci; 1996 Sep; 17(9):331-6. PubMed ID: 8885699
[TBL] [Abstract][Full Text] [Related]
14. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
15. Allergic airway inflammation and beta-adrenoceptor dysfunction.
Brusasco V; Crimi E; Baroffio M
Cell Biochem Biophys; 2006; 44(1):129-38. PubMed ID: 16456241
[TBL] [Abstract][Full Text] [Related]
16. [Genetic polymorphism of beta 2-adrenoreceptor and its role in pathologic states].
Woszczek G; Kowalski ML
Postepy Hig Med Dosw; 2001; 55(1):37-51. PubMed ID: 11355533
[TBL] [Abstract][Full Text] [Related]
17. QSAR and the rational design of long-acting dual D2-receptor/beta 2-adrenoceptor agonists.
Austin RP; Barton P; Bonnert RV; Brown RC; Cage PA; Cheshire DR; Davis AM; Dougall IG; Ince F; Pairaudeau G; Young A
J Med Chem; 2003 Jul; 46(15):3210-20. PubMed ID: 12852752
[TBL] [Abstract][Full Text] [Related]
18. Alpha2C-adrenergic receptors exhibit enhanced surface expression and signaling upon association with beta2-adrenergic receptors.
Prinster SC; Holmqvist TG; Hall RA
J Pharmacol Exp Ther; 2006 Sep; 318(3):974-81. PubMed ID: 16757535
[TBL] [Abstract][Full Text] [Related]
19. The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting.
Ryall JG; Lynch GS
Pharmacol Ther; 2008 Dec; 120(3):219-32. PubMed ID: 18834902
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of B2-agonists action and safety aspects].
Chorostowska-Wynimko J
Pol Merkur Lekarski; 2002 Jun; 12(72):441-4. PubMed ID: 12362656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
